Oritavancin

Kathryn Dzintars, PharmD, BCPS, Paul A. Pham, Pharm.D. BCPS

Oritavancin is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please log in or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Monkeypox

Coronavirus COVID-19 (SARS-CoV-2)

Suicide Risk in the COVID-19 Pandemic

Moderna COVID-19 Vaccine

BNT162b2 COVID-19 Vaccine (BioNTech/Pfizer)

Managing Stress and Coping with COVID-19

Johnson & Johnson COVID-19 Vaccine

-- The first section of this topic is shown below --

INDICATIONS

FDA

Acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible Gram-positive organisms

-- To view the remaining sections of this topic, please log in or purchase a subscription --

INDICATIONS

FDA

Acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible Gram-positive organisms

There's more to see -- the rest of this topic is available only to subscribers.